AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Byline: Bruce Japsen
CHICAGO _ Amid criticism of its monitoring of drug safety after products reach the market, the Food and Drug Administration disclosed Thursday it is conducting a safety review of two of the world's most widely sold heartburn drugs _ Nexium and Prilosec _ after two small studies linked the medicines to potential heart attacks and death.
The agency said, however, that patients could continue taking Nexium and Prilosec, which is also sold in generic and over-the-counter form, because its larger review so far does not show an increased heart attack risk.
Both drugs are taken by tens of millions around the world and fall into the…